Astrana Capital Stock from 2010 to 2024

ASTH Stock

33.48 0.01 0.03%

Astrana Health's Capital Stock is increasing with slightly volatile movements from year to year. Capital Stock is predicted to flatten to about 46.1 K. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

54 K

Current Value

46.1 K

Quarterly Volatility

6.4 K

Credit Downgrade

Yuan Drop

Covid

Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 16.9 M, Other Operating Expenses of 1.4 B or Operating Income of 88.8 M, as well as many indicators such as Price To Sales Ratio of 1.33, Dividend Yield of 0.0428 or PTB Ratio of 4.22. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

Latest Astrana Health's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Astrana Health over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Astrana Health's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Astrana Capital Stock Regression Statistics

	Arithmetic Mean	38,751
	Geometric Mean	38,309
	Coefficient Of Variation	16.47
	Mean Deviation	5,387
	Median	34,578
	Standard Deviation	6,384
	Sample Variance	40.8M
	Range	19.5K
	R-Value	0.82
	Mean Square Error	14.7M
	R-Squared	0.67
	Significance	0.0002
	Slope	1,165
	Total Sum of Squares	570.6M

Astrana Capital Stock History

	2024	46.1 K
	2023	54 K
	2022	47 K
	2021	45 K
	2020	42 K
	2019	35.9 K

Other Fundumenentals of Astrana Health

Issuance Of Capital Stock

Astrana Health Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	0.12	0.86	0.55	0.96	0.99	0.48	0.73	0.94	0.87	0.45	0.91	0.94	0.44	0.9	0.96	0.51	0.85	0.85	0.42	0.75	0.89	0.94	0.82
Total Stockholder Equity	0.94		0.05	0.97	0.45	0.96	0.97	0.48	0.78	0.96	0.96	0.25	0.89	0.81	0.19	0.87	0.99	0.29	0.66	0.97	0.52	0.63	0.93	0.89	0.93
Net Debt	0.12	0.05		0.09	-0.31	0.29	0.2	0.05	0.44	0.22	-0.07	0.19	0.48	0.05	0.68	0.5	0.04	0.29	-0.02	0.09	0.49	-0.18	0.23	0.28	0.11
Retained Earnings	0.86	0.97	0.09		0.32	0.92	0.91	0.49	0.79	0.94	0.95	0.11	0.86	0.69	0.08	0.83	0.95	0.17	0.5	0.99	0.59	0.47	0.91	0.83	0.95
Accounts Payable	0.55	0.45	-0.31	0.32		0.47	0.46	0.15	0.4	0.36	0.38	0.05	0.3	0.61	0.1	0.3	0.51	0.05	0.73	0.35	0.21	0.55	0.3	0.29	0.28
Total Liab	0.96	0.96	0.29	0.92	0.47		0.99	0.47	0.86	0.97	0.87	0.33	0.97	0.85	0.42	0.96	0.96	0.41	0.73	0.91	0.6	0.62	0.92	0.92	0.88
Total Current Assets	0.99	0.97	0.2	0.91	0.46	0.99		0.49	0.78	0.97	0.89	0.41	0.95	0.89	0.42	0.94	0.98	0.46	0.77	0.9	0.48	0.68	0.93	0.96	0.87
Common Stock	0.48	0.48	0.05	0.49	0.15	0.47	0.49		0.28	0.45	0.46	0.16	0.46	0.51	0.18	0.45	0.48	0.14	0.38	0.44	0.21	0.02	0.55	0.51	0.52
Short Term Debt	0.73	0.78	0.44	0.79	0.4	0.86	0.78	0.28		0.81	0.74	0.08	0.84	0.57	0.26	0.81	0.79	0.23	0.48	0.8	0.88	0.42	0.72	0.63	0.75
Net Receivables	0.94	0.96	0.22	0.94	0.36	0.97	0.97	0.45	0.81		0.91	0.29	0.93	0.82	0.33	0.91	0.96	0.45	0.68	0.93	0.54	0.6	0.91	0.91	0.87
Net Tangible Assets	0.87	0.96	-0.07	0.95	0.38	0.87	0.89	0.46	0.74	0.91		0.16	0.79	0.74	0.0	0.75	0.95	0.29	0.59	0.95	0.5	0.64	0.85	0.79	0.89
Current Deferred Revenue	0.45	0.25	0.19	0.11	0.05	0.33	0.41	0.16	0.08	0.29	0.16		0.39	0.53	0.71	0.42	0.3	0.71	0.55	0.04	-0.14	0.6	0.31	0.53	0.16
Long Term Debt	0.91	0.89	0.48	0.86	0.3	0.97	0.95	0.46	0.84	0.93	0.79	0.39		0.79	0.55	1.0	0.89	0.44	0.65	0.85	0.6	0.53	0.92	0.94	0.84
Good Will	0.94	0.81	0.05	0.69	0.61	0.85	0.89	0.51	0.57	0.82	0.74	0.53	0.79		0.51	0.79	0.85	0.57	0.94	0.67	0.25	0.76	0.81	0.87	0.71
Short Term Investments	0.44	0.19	0.68	0.08	0.1	0.42	0.42	0.18	0.26	0.33	0.0	0.71	0.55	0.51		0.59	0.22	0.66	0.55	0.04	0.1	0.29	0.32	0.54	0.09
Long Term Debt Total	0.9	0.87	0.5	0.83	0.3	0.96	0.94	0.45	0.81	0.91	0.75	0.42	1.0	0.79	0.59		0.87	0.44	0.65	0.82	0.56	0.53	0.91	0.94	0.82
Capital Surpluse	0.96	0.99	0.04	0.95	0.51	0.96	0.98	0.48	0.79	0.96	0.95	0.3	0.89	0.85	0.22	0.87		0.34	0.72	0.94	0.51	0.69	0.91	0.89	0.91
Deferred Long Term Liab	0.51	0.29	0.29	0.17	0.05	0.41	0.46	0.14	0.23	0.45	0.29	0.71	0.44	0.57	0.66	0.44	0.34		0.65	0.13	0.0	0.61	0.26	0.49	0.1
Intangible Assets	0.85	0.66	-0.02	0.5	0.73	0.73	0.77	0.38	0.48	0.68	0.59	0.55	0.65	0.94	0.55	0.65	0.72	0.65		0.49	0.18	0.79	0.59	0.71	0.47
Property Plant Equipment	0.85	0.97	0.09	0.99	0.35	0.91	0.9	0.44	0.8	0.93	0.95	0.04	0.85	0.67	0.04	0.82	0.94	0.13	0.49		0.59	0.48	0.91	0.82	0.94
Short Long Term Debt	0.42	0.52	0.49	0.59	0.21	0.6	0.48	0.21	0.88	0.54	0.5	-0.14	0.6	0.25	0.1	0.56	0.51	0.0	0.18	0.59		0.05	0.47	0.33	0.54
Long Term Investments	0.75	0.63	-0.18	0.47	0.55	0.62	0.68	0.02	0.42	0.6	0.64	0.6	0.53	0.76	0.29	0.53	0.69	0.61	0.79	0.48	0.05		0.52	0.63	0.46
Net Invested Capital	0.89	0.93	0.23	0.91	0.3	0.92	0.93	0.55	0.72	0.91	0.85	0.31	0.92	0.81	0.32	0.91	0.91	0.26	0.59	0.91	0.47	0.52		0.94	0.96
Net Working Capital	0.94	0.89	0.28	0.83	0.29	0.92	0.96	0.51	0.63	0.91	0.79	0.53	0.94	0.87	0.54	0.94	0.89	0.49	0.71	0.82	0.33	0.63	0.94		0.84
Capital Stock	0.82	0.93	0.11	0.95	0.28	0.88	0.87	0.52	0.75	0.87	0.89	0.16	0.84	0.71	0.09	0.82	0.91	0.1	0.47	0.94	0.54	0.46	0.96	0.84

Click cells to compare fundamentals

About Astrana Health Financial Statements

Investors use fundamental indicators, such as Astrana Health's Capital Stock, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

		Last Reported	Projected for Next Year
	Capital Stock	54 K	46.1 K

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Astrana Health Correlation against competitors.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

1.3

Revenue Per Share

36.415

Quarterly Revenue Growth

0.375

Return On Assets

0.0449

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Astrana Capital Stock from 2010 to 2024

Latest Astrana Health's Capital Stock Growth Pattern

Astrana Capital Stock Regression Statistics

Astrana Capital Stock History

Other Fundumenentals of Astrana Health

Astrana Health Capital Stock component correlations

About Astrana Health Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY